AtriCure, Inc. (ATRC) is a publicly traded Healthcare sector company. As of May 21, 2026, ATRC trades at $30.91 with a market cap of $1.44B and a P/E ratio of -288.90. ATRC moved +0.69% today. Year to date, ATRC is -28.43%; over the trailing twelve months it is -14.83%. Its 52-week range spans $25.52 to $43.18. Analyst consensus is strong buy with an average price target of $50.29. Rallies surfaces ATRC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ATRC financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ATRC recently traded at $30.91. Market cap is $1.44B. P/E ratio is -288.90. Revenue is $552.16M.
| Metric | Value |
|---|---|
| Price | $30.91 |
| Market Cap | $1.44B |
| P/E Ratio | -288.90 |
| EPS | $-0.10 |
| Dividend Yield | 0.00% |
| 52-Week High | $43.18 |
| 52-Week Low | $25.52 |
| Volume | 171 |
| Avg Volume | 0 |
| Revenue (TTM) | $552.16M |
| Net Income | $-4.59M |
| Gross Margin | 75.61% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $534.53M | $-11.45M | $-0.24 |
| 2023 | $399.25M | $-30.44M | $-0.66 |
| 2022 | $330.38M | $-46.47M | $-1.02 |
| 2021 | $274.33M | $50.20M | $1.11 |
8 analysts cover ATRC: 0 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $50.29.